The present series of studies have examined the functional activity of rat large granular lymphocytes (LGL), the population of cells known to mediate natural killer (NK) and antibody-dependent cellular cytotoxicity (ADCC). The administration of antibody GMl antibody decreased NK activity and increased tumor growth, as well as reduced resistance to hematopoietic grafts. The adoptive transfer of LGL into rats with depressed NK/ADCC activity was shown to restore antitumor activity, as well as inhibit the development of syngeneic bone marrow stem cells. These results provide the first direct evidence for an important role for LGL in the control of bone marrow growth and differentiation. These results also suggest that the adoptive transfer of highly enriched LGL populations should be further considered as one potential immunotherapeutic regimen in cancer patients. In addition, protocols involving the depletion of host NK activity in bone marrow transplantation recipients should be further considered. In other experiments we have shown a number of differences in the organ, age and strain distribution between the NK and ADCC effector cell (killer cell) populations. Studies with the BRM, 0K432, have shown this agent to augment NK activity and increase survival of tumor-bearing rats.

Agency
National Institute of Health (NIH)
Institute
Division of Cancer Treatment (NCI)
Type
Intramural Research (Z01)
Project #
1Z01CM009257-06
Application #
3916659
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
6
Fiscal Year
1988
Total Cost
Indirect Cost
Name
Cancer Treatment
Department
Type
DUNS #
City
State
Country
United States
Zip Code